HomeTOP STORIESBridgeBio outlines transition to cash generation by 2028 with $600M profit target,... BridgeBio outlines transition to cash generation by 2028 with $600M profit target, driven by pipeline advances and Attruby growth By rogerjudd February 25, 2026 FacebookTwitterPinterestWhatsApp Post Content Previous articleONEOK outlines $8.1B 2026 EBITDA target while advancing integration and project deliveryNext articleApple Hospitality outlines flat RevPAR guidance for 2026 while advancing management transitions and asset optimization latest articles The inflation process has shifted even as headline CPI declined – Federal Reserve Cerrado Gold reports Q4 results As H-1B Visa Program Changes, Skilled Foreign Workers Consider Leaving U.S. They Get Drunk Without Drinking: What It’s Like to Have Auto-brewery Syndrome Parents Who Borrowed for Children’s College Face Looming Deadline Watch: Artemis II’s journey so far… in 85 seconds explore more The inflation process has shifted even as headline CPI declined – Federal Reserve Cerrado Gold reports Q4 results As H-1B Visa Program Changes, Skilled Foreign Workers Consider Leaving U.S. They Get Drunk Without Drinking: What It’s Like to Have Auto-brewery Syndrome Parents Who Borrowed for Children’s College Face Looming Deadline Watch: Artemis II’s journey so far… in 85 seconds
